Income Statement Grifols, S.A.

Equities

GRF

ES0171996087

Pharmaceuticals

Real-time Estimate Tradegate Other stock markets 14:54:20 15/12/2025 GMT			5-day change	1st Jan Change
10.84 ^EUR	+0.51%		+0.32%	+18.66%

12-04	Grifols achieves self-sufficiency in plasma-derived medicines in Egypt	RE
12-03	European Equities Traded in the US as American Depositary Receipts Higher in Wednesday Trading	MT

a370ddfeecfd3550430827e312.-ZrdCRs6bNyiM8wHZWdV8MLKD4r4TtXIxI14yjjjOJA.lvSFcHxsVaj9Zr53HQgxv7P5Xtq7JeWfs706r1-ZWaiJ259GTWolptEHow

Published financial data: GRIFOLS, S.A.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	5.34B	4.93B	6.06B	6.59B	7.21B
Total Revenues	5.34B	4.93B	6.06B	6.59B	7.21B
Cost of Goods Sold, Total	3.08B	2.97B	3.83B	4.1B	4.36B
Gross Profit	2.26B	1.96B	2.23B	2.49B	2.85B
Selling General & Admin Expenses, Total	986M	1.06B	1.19B	1.37B	1.17B
R&D Expenses	294M	355M	361M	395M	363M
Other Operating Expenses	-	-16.3M	-14.68M	-3.04M	-
Other Operating Expenses, Total	1.28B	1.4B	1.54B	1.76B	1.53B
Operating Income	975M	563M	695M	736M	1.32B
Interest Expense, Total	-223M	-234M	-363M	-443M	-602M
Interest And Investment Income	8.02M	11.55M	33.86M	62.33M	46.48M
Net Interest Expenses	-215M	-222M	-329M	-380M	-556M
Income (Loss) On Equity Invest.	80.96M	65.74M	102M	62.82M	36.8M
Currency Exchange Gains (Loss)	8.25M	-11.6M	7.72M	-16.39M	-59.76M
Other Non Operating Income (Expenses)	28.98M	-43.94M	-122M	-153M	-132M
EBT, Excl. Unusual Items	879M	350M	354M	249M	608M
Merger & Related Restructuring Charges	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Gain (Loss) On Sale Of Assets	-	-	7.56M	-24.99M	-
Asset Writedown	-	-	-	-	-
Other Unusual Items	-	-	-	-	-164M
EBT, Incl. Unusual Items	879M	350M	361M	224M	444M
Income Tax Expense	170M	85.13M	90.11M	43.35M	231M
Earnings From Continuing Operations	709M	265M	271M	181M	213M
Net Income to Company	709M	265M	271M	181M	213M
Minority Interest	-90.44M	-82.52M	-62.87M	-121M	-55.89M
Net Income - (IS)	619M	183M	208M	59.32M	157M
Net Income to Common Incl Extra Items	619M	183M	208M	59.32M	157M
Net Income to Common Excl. Extra Items	619M	183M	208M	59.32M	157M
Per Share Items
Net EPS - Basic	0.9	0.27	0.31	0.09	0.23
Basic EPS - Continuing Operations	0.9	0.27	0.31	0.09	0.23
Basic Weighted Average Shares Outstanding	686M	682M	680M	680M	680M
Net EPS - Diluted	0.9	0.27	0.31	0.09	0.23
Diluted EPS - Continuing Operations	0.9	0.27	0.31	0.09	0.23
Diluted Weighted Average Shares Outstanding	686M	682M	680M	680M	680M
Normalized Basic EPS	0.67	0.2	0.23	0.05	0.48
Normalized Diluted EPS	0.67	0.2	0.23	0.05	0.48
Dividend Per Share	0.36	-	-	-	-
Payout Ratio	18.31	141.65	0.28	-	0.61
American Depositary Receipts Ratio (ADR)	0.5	0.5	0.5	0.5	0.5
Supplemental Items
EBITDA	1.19B	785M	963M	1.03B	1.61B
EBITA	1.03B	613M	760M	816M	1.39B
EBIT	975M	563M	695M	736M	1.32B
EBITDAR	1.22B	818M	1B	1.08B	1.66B
Effective Tax Rate - (Ratio)	19.31	24.29	24.94	19.35	52.07
Total Current Taxes	127M	67.37M	105M	183M	306M
Total Deferred Taxes	43.14M	17.75M	-15.14M	-140M	-75.07M
Normalized Net Income	459M	137M	158M	34.28M	324M
Interest Capitalized	16.61M	18.64M	25.18M	36.89M	27.77M
Interest on Long-Term Debt	240M	252M	388M	479M	561M
Non-Cash Pension Expense	-	-	766K	3.44M	3.09M
Supplemental Operating Expense Items
Advertising Expense	55.07M	71.28M	90.65M	78.85M	83.9M
Research And Development Expense From Footnotes	294M	355M	361M	395M	384M
Net Rental Expense, Total	28.18M	32.94M	38.99M	43.04M	47.12M
Imputed Operating Lease Interest Expense	7.69M	8.19M	11.57M	15.43M	22.48M
Imputed Operating Lease Depreciation	20.49M	24.76M	27.43M	27.61M	24.65M
Maintenance & Repair Expenses, Total	147M	150M	219M	231M	270M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	580M	655M	548M	530M	980M
Short Term Investments	11.02M	2.03B	30.99M	116M	24.18M
Trading Asset Securities, Total	-	3.24M	-	-	-
Total Cash And Short Term Investments	591M	2.69B	579M	646M	1B
Accounts Receivable, Total	383M	434M	644M	693M	741M
Other Receivables	121M	61.3M	111M	118M	125M
Notes Receivable	95K	39K	48K	120K	213M
Total Receivables	504M	495M	755M	811M	1.08B
Inventory	2B	2.26B	3.2B	3.46B	3.56B
Other Current Assets, Total	67.8M	70.29M	118M	1.54B	84.17M
Total Current Assets	3.16B	5.51B	4.65B	6.45B	5.73B
Gross Property Plant And Equipment	4.47B	5.11B	6.24B	6.46B	6.94B
Accumulated Depreciation	-1.47B	-1.77B	-2.07B	-2.27B	-2.63B
Net Property Plant And Equipment	3B	3.34B	4.17B	4.19B	4.31B
Long-term Investments	1.98B	2.27B	2.44B	565M	529M
Goodwill	5.33B	6.23B	7.01B	6.8B	7.4B
Other Intangibles, Total	982M	1B	1.33B	1.21B	1.19B
Accounts Receivable Long-Term	-	-	-	-	59K
Loans Receivable Long-Term	80.85M	89.1M	96.54M	137M	19.92M
Deferred Tax Assets Long-Term	150M	153M	175M	305M	342M
Deferred Charges Long-Term	576M	633M	1.62B	1.62B	1.74B
Other Long-Term Assets, Total	6.27M	7.76M	36.31M	155M	148M
Total Assets	15.27B	19.23B	21.53B	21.44B	21.41B
Liabilities
Accounts Payable, Total	602M	629M	732M	813M	852M
Accrued Expenses, Total	263M	328M	314M	371M	451M
Current Portion of Long-Term Debt	279M	2.35B	693M	906M	560M
Current Portion of Leases	42.64M	48.57M	102M	107M	117M
Current Income Taxes Payable	3.48M	4.52M	15.69M	14.52M	60.54M
Unearned Revenue Current, Total	22.93M	32.97M	27.64M	28.87M	36.5M
Other Current Liabilities	123M	85.36M	71.33M	74.59M	79.89M
Total Current Liabilities	1.34B	3.47B	1.96B	2.32B	2.16B
Long-Term Debt	5.91B	6.11B	9.04B	8.63B	8.42B
Long-Term Leases	691M	825M	915M	1B	1.02B
Unearned Revenue Non Current	17.01M	15.04M	15.12M	13.81M	13.94M
Pension & Other Post Retirement Benefits	6.77M	6.72M	94.07M	100M	102M
Deferred Tax Liability Non Current	557M	634M	1.03B	989M	1.01B
Other Non Current Liabilities	36.9M	17.74M	20.82M	414M	68.34M
Total Liabilities	8.55B	11.09B	13.08B	13.47B	12.8B
Common Stock, Total	120M	120M	120M	120M	120M
Additional Paid In Capital	911M	911M	911M	911M	911M
Retained Earnings	689M	242M	257M	96.35M	206M
Treasury Stock	-43.73M	-164M	-162M	-153M	-134M
Comprehensive Income and Other	3.43B	4.99B	5B	4.85B	4.78B
Total Common Equity	5.11B	6.1B	6.13B	5.83B	5.88B
Minority Interest	1.61B	2.05B	2.33B	2.15B	2.72B
Total Equity	6.72B	8.15B	8.46B	7.97B	8.61B
Total Liabilities And Equity	15.27B	19.23B	21.53B	21.44B	21.41B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	685M	679M	678M	679M	680M
ECS Total Common Shares Outstanding	685M	679M	678M	679M	680M
Book Value / Share	7.46	8.98	9.04	8.58	8.65
Tangible Book Value	-1.21B	-1.14B	-2.21B	-2.18B	-2.71B
Tangible Book Value Per Share	-1.76	-1.67	-3.26	-3.21	-3.98
Total Debt	6.92B	9.33B	10.75B	10.65B	10.12B
Net Debt	6.33B	6.65B	10.17B	10B	9.12B
Debt Equivalent of Unfunded Proj. Benefit Obligation	-	-	85.82M	100M	102M
Debt Equivalent Oper. Leases	225M	264M	312M	344M	377M
Minority Interest, Total (Incl. Fin. Div)	1.61B	2.05B	2.33B	2.15B	2.72B
Equity Method Investments, Total	1.87B	2B	1.96B	535M	69M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	595M	657M	1.06B	1.1B	956M
Inventories - Work In Process, Total	594M	721M	1.33B	1.21B	1.41B
Inventories - Finished Goods, Total	813M	881M	805M	1.14B	1.2B
Land - (BS)	780M	860M	1.16B	1.13B	1.23B
Machinery, Total	2.2B	2.53B	3.07B	3.18B	3.55B
Full Time Employees	23.67K	23.24K	26.33K	23.74K	23.83K
Part Time Employees	-	-	-	-	-
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	22.98M	24.01M	32.29M	31.58M	10.35M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	619M	183M	208M	59.32M	157M
Depreciation & Amortization - CF	226M	240M	284M	295M	304M
Amortization of Goodwill and Intangible Assets - (CF)	52.8M	50.16M	65.14M	80.15M	66.64M
Depreciation & Amortization, Total	279M	290M	349M	375M	371M
Amortization of Deferred Charges, Total - (CF)	43.01M	70.09M	58.52M	67.06M	67.04M
(Gain) Loss From Sale Of Asset	1.07M	1.2M	-1.73M	7.18M	1.38M
Asset Writedown & Restructuring Costs	-17.15M	64.09M	69.98M	101M	73.26M
(Income) Loss On Equity Investments - (CF)	-80.96M	-65.74M	-102M	-62.82M	-36.8M
Other Operating Activities, Total	161M	196M	15.95M	31.35M	247M
Change In Accounts Receivable	-35.43M	-16.81M	-80.17M	-53.14M	-41.88M
Change In Inventories	165M	-157M	-600M	-427M	25.82M
Change In Accounts Payable	-2.32M	40.45M	80.21M	103M	28.8M
Change in Other Net Operating Assets	-20.6M	-7.08M	-9.01M	7.36M	9.64M
Cash from Operations	1.11B	597M	-10.87M	208M	902M
Capital Expenditure	-280M	-247M	-266M	-210M	-233M
Sale of Property, Plant, and Equipment	272K	639K	3.28M	5.43M	23.5M
Cash Acquisitions	-469M	-519M	-1.53B	-29.47M	-286M
Divestitures	-	794M	91.37M	-	-
Sale (Purchase) of Intangible assets	-82.41M	-67.72M	-109M	-85.88M	-139M
Investment in Marketable and Equity Securities, Total	-27.24M	9.82M	-165M	-78.17M	1.52B
Cash from Investing	-858M	-29.39M	-1.98B	-398M	887M
Long-Term Debt Issued, Total	109M	2.46B	1.13B	1.64B	4.01B
Total Debt Issued	109M	2.46B	1.13B	1.64B	4.01B
Long-Term Debt Repaid, Total	-431M	-578M	-1.31B	-1.46B	-5.36B
Total Debt Repaid	-431M	-578M	-1.31B	-1.46B	-5.36B
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-	-126M	-3.46M	-	-
Common Dividends Paid	-111M	-	-	-	-
Preferred Dividends Paid	-2.61M	-	-	-	-
Common & Preferred Stock Dividends Paid	-	-259M	-592K	-	-962K
Common & Preferred Stock Dividends Paid	-113M	-259M	-592K	-	-962K
Other Financing Activities, Total	81.24M	-20.94M	7.93M	5.47M	-5.48M
Cash from Financing	-354M	1.47B	-173M	186M	-1.36B
Foreign Exchange Rate Adjustments	-60.16M	55.46M	35.55M	-15.09M	20.08M
Net Change in Cash	-162M	2.1B	-2.13B	-18.4M	450M
Supplemental Items
Cash Interest Paid	156M	155M	350M	529M	571M
Cash Income Tax Paid (Refund)	132M	30.6M	196M	159M	176M
Levered Free Cash Flow	714M	64.88M	-925M	-1.26B	1.45B
Unlevered Free Cash Flow	853M	211M	-698M	-984M	1.83B
Change In Net Working Capital	-285M	185M	1.16B	1.59B	-940M
Net Debt Issued / Repaid	-322M	1.88B	-177M	181M	-1.35B

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	3.96	2.04	2.13	2.14	3.89
Return on Total Capital	4.42	2.26	2.37	2.43	4.43
Return On Equity %	10.45	3.57	3.44	2.2	2.64
Return on Common Equity	12.46	3.26	3.57	0.99	2.79
Margin Analysis
Gross Profit Margin %	42.23	39.78	36.8	37.84	39.48
SG&A Margin	18.46	21.52	19.63	20.73	16.16
EBITDA Margin %	22.31	15.92	15.89	15.65	22.3
EBITA Margin %	19.25	12.42	12.53	12.38	19.22
EBIT Margin %	18.26	11.4	11.46	11.16	18.3
Income From Continuing Operations Margin %	13.28	5.38	4.47	2.74	2.95
Net Income Margin %	11.58	3.71	3.43	0.9	2.18
Net Avail. For Common Margin %	11.58	3.71	3.43	0.9	2.18
Normalized Net Income Margin	8.59	2.77	2.61	0.52	4.5
Levered Free Cash Flow Margin	13.37	1.32	-15.25	-19.12	20.16
Unlevered Free Cash Flow Margin	15.98	4.28	-11.51	-14.92	25.38
Asset Turnover
Asset Turnover	0.35	0.29	0.3	0.31	0.34
Fixed Assets Turnover	1.82	1.55	1.61	1.58	1.7
Receivables Turnover (Average Receivables)	14.18	12.07	11.25	9.86	10.06
Inventory Turnover (Average Inventory)	1.42	1.39	1.4	1.23	1.24
Short Term Liquidity
Current Ratio	2.37	1.59	2.38	2.79	2.66
Quick Ratio	0.82	0.92	0.68	0.63	0.87
Operating Cash Flow to Current Liabilities	0.83	0.17	-0.01	0.09	0.42
Days Sales Outstanding (Average Receivables)	25.81	30.24	32.44	37.01	36.39
Days Outstanding Inventory (Average Inventory)	257.75	261.82	260.04	296.67	295.27
Average Days Payable Outstanding	78.91	69.58	52.02	64.74	69.01
Cash Conversion Cycle (Average Days)	204.64	222.48	240.46	268.93	262.66
Long Term Solvency
Total Debt/Equity	103.03	114.57	127.11	133.58	117.6
Total Debt / Total Capital	50.75	53.39	55.97	57.19	54.04
LT Debt/Equity	98.24	85.17	117.71	120.87	109.75
Long-Term Debt / Total Capital	48.39	39.69	51.83	51.75	50.43
Total Liabilities / Total Assets	56.01	57.64	60.72	62.82	59.79
EBIT / Interest Expense	4.38	2.41	1.92	1.66	2.19
EBITDA / Interest Expense	5.62	3.64	2.88	2.51	2.81
(EBITDA - Capex) / Interest Expense	4.37	2.59	2.14	2.04	2.42
Total Debt / EBITDA	5.52	10.95	10.3	9.59	5.99
Net Debt / EBITDA	5.05	7.8	9.74	9.01	5.39
Total Debt / (EBITDA - Capex)	7.11	15.43	13.83	11.82	6.94
Net Debt / (EBITDA - Capex)	6.5	10.99	13.08	11.1	6.25
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	4.73	-7.62	22.92	8.71	9.41
Gross Profit, 1 Yr. Growth %	-3.68	-12.97	13.7	11.79	11.69
EBITDA, 1 Yr. Growth %	-10.91	-34.06	22.66	7.11	27.45
EBITA, 1 Yr. Growth %	-12.5	-40.41	24.01	7.37	33.13
EBIT, 1 Yr. Growth %	-13.1	-42.33	23.49	5.9	37.3
Earnings From Cont. Operations, 1 Yr. Growth %	9.3	-62.58	2.19	-33.37	30.02
Net Income, 1 Yr. Growth %	-1.06	-70.45	10.36	-71.52	270.81
Normalized Net Income, 1 Yr. Growth %	-10.19	-70.24	11.07	-79.79	103.21
Diluted EPS Before Extra, 1 Yr. Growth %	-1.1	-70.2	10.64	-71.52	283.33
Accounts Receivable, 1 Yr. Growth %	3.63	13.28	48.3	7.61	7.01
Inventory, 1 Yr. Growth %	-14.53	12.84	41.69	8.06	2.23
Net Property, Plant and Equip., 1 Yr. Growth %	4.87	11.33	24.69	0.57	2.81
Total Assets, 1 Yr. Growth %	-1.72	25.92	11.96	-0.43	1.97
Tangible Book Value, 1 Yr. Growth %	-32.5	-5.81	29.23	-1.18	2.56
Common Equity, 1 Yr. Growth %	5.94	19.35	10.98	-4.94	9.6
Cash From Operations, 1 Yr. Growth %	95.16	-46.23	-101.82	-2.02K	312.53
Capital Expenditures, 1 Yr. Growth %	-9.74	-11.7	7.73	-21.37	3.61
Levered Free Cash Flow, 1 Yr. Growth %	-19.38K	-90.91	-1.6K	36.28	-186.69
Unlevered Free Cash Flow, 1 Yr. Growth %	328.62	-75.26	-436.28	40.91	-235.1
Dividend Per Share, 1 Yr. Growth %	-0.55	-	-	-	-
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	9.1	-1.64	6.56	15.6	9.06
Gross Profit, 2 Yr. CAGR %	4.9	-8.44	-0.53	12.74	13.42
EBITDA, 2 Yr. CAGR %	-1.29	-25.75	-13.81	5.78	21.9
EBITA, 2 Yr. CAGR %	1.7	-26.12	-11.74	20.43	43.69
EBIT, 2 Yr. CAGR %	-0.95	-29.21	-15.61	14.36	40.19
Earnings From Cont. Operations, 2 Yr. CAGR %	9.21	-36.04	-38.16	-17.48	-7.35
Net Income, 2 Yr. CAGR %	1.82	-45.92	-41.97	-43.94	-7.91
Normalized Net Income, 2 Yr. CAGR %	2.46	-48.3	-41.27	-52.01	50.24
Diluted EPS Before Extra, 2 Yr. CAGR %	1.71	-45.71	-41.65	-43.86	-7.7
Accounts Receivable, 2 Yr. CAGR %	19.32	8.35	29.62	26.33	7.28
Inventory, 2 Yr. CAGR %	1.35	-1.79	26.45	23.74	4.89
Net Property, Plant and Equip., 2 Yr. CAGR %	24.03	8.05	17.82	11.98	0.3
Total Assets, 2 Yr. CAGR %	10.64	11.24	18.73	5.58	0.41
Tangible Book Value, 2 Yr. CAGR %	-23.89	-20.26	35.32	13.01	0.35
Common Equity, 2 Yr. CAGR %	9.95	12.44	9.54	2.71	2.06
Cash From Operations, 2 Yr. CAGR %	22.71	2.43	-90.11	-40.93	2.41K
Capital Expenditures, 2 Yr. CAGR %	9.89	-10.73	-2.47	-7.96	-9.48
Levered Free Cash Flow, 2 Yr. CAGR %	132.89	318.61	13.82	352.8	182.56
Unlevered Free Cash Flow, 2 Yr. CAGR %	67.81	2.97	-9.54	117.68	337.45
Dividend Per Share, 2 Yr. CAGR %	2.13	-	-	-	-
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	7.34	3.21	5.95	7.27	13.5
Gross Profit, 3 Yr. CAGR %	1.57	-1.43	-1.59	3.42	13.21
EBITDA, 3 Yr. CAGR %	-2.43	-13.72	-12.23	-7.33	20.36
EBITA, 3 Yr. CAGR %	-1.23	-14.9	-12.2	-5.78	35.07
EBIT, 3 Yr. CAGR %	-2.95	-17.29	-14.78	-8.97	32.87
Earnings From Cont. Operations, 3 Yr. CAGR %	2.35	-23.58	-25.23	-36.6	-7.09
Net Income, 3 Yr. CAGR %	-2.27	-32.58	-30.68	-54.23	-5.97
Normalized Net Income, 3 Yr. CAGR %	-2.03	-32.15	-32.34	-57.88	29.63
Diluted EPS Before Extra, 3 Yr. CAGR %	-2.42	-32.45	-30.43	-54.06	-6
Accounts Receivable, 3 Yr. CAGR %	10.22	17.27	20.3	21.82	19.53
Inventory, 3 Yr. CAGR %	7.11	5.04	10.97	19.99	16.37
Net Property, Plant and Equip., 3 Yr. CAGR %	19.49	19.64	13.34	11.77	8.84
Total Assets, 3 Yr. CAGR %	11.84	15.52	11.48	11.97	3.63
Tangible Book Value, 3 Yr. CAGR %	-15.49	-18.29	7.32	21.86	16.6
Common Equity, 3 Yr. CAGR %	12.07	13	8.33	4.49	2.13
Cash From Operations, 3 Yr. CAGR %	9.67	-6.8	-73.27	-42.76	14.76
Capital Expenditures, 3 Yr. CAGR %	3.66	2.16	-4.96	-9.23	-2.04
Levered Free Cash Flow, 3 Yr. CAGR %	9.14	-21	529.77	20.87	187.08
Unlevered Free Cash Flow, 3 Yr. CAGR %	6.56	-11.36	51.94	4.86	106.6
Dividend Per Share, 3 Yr. CAGR %	-1.79	-	-	-	-
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	6.3	4.02	7.03	8	7.18
Gross Profit, 5 Yr. CAGR %	3.15	0.52	0.73	4.01	3.99
EBITDA, 5 Yr. CAGR %	0.53	-7.2	-5.56	-3.34	2.45
EBITA, 5 Yr. CAGR %	1.16	-8.19	-6.57	-3.88	4.31
EBIT, 5 Yr. CAGR %	0.1	-9.75	-8.23	-5.84	3.29
Earnings From Cont. Operations, 5 Yr. CAGR %	5.93	-13.39	-16.33	-21.19	-19.98
Net Income, 5 Yr. CAGR %	3.05	-19.64	-20.66	-36.98	-24.15
Normalized Net Income, 5 Yr. CAGR %	1.2	-21.1	-20.17	-39.89	-8.68
Diluted EPS Before Extra, 5 Yr. CAGR %	2.94	-19.6	-20.56	-36.87	-24.05
Accounts Receivable, 5 Yr. CAGR %	1.12	0.97	17.6	20.82	14.93
Inventory, 5 Yr. CAGR %	6.94	6.58	14.46	12.16	8.73
Net Property, Plant and Equip., 5 Yr. CAGR %	12.8	13.06	18.82	16.52	8.52
Total Assets, 5 Yr. CAGR %	9.73	13.68	14.55	11.44	6.61
Tangible Book Value, 5 Yr. CAGR %	-2.27	1.64	2.02	0.95	8.68
Common Equity, 5 Yr. CAGR %	9.16	10.38	11.05	6.64	4.06
Cash From Operations, 5 Yr. CAGR %	8.37	1.53	-58.1	-22.34	9.66
Capital Expenditures, 5 Yr. CAGR %	-11.72	-0.16	1.16	-2.01	-5.61
Levered Free Cash Flow, 5 Yr. CAGR %	54.85	-4.52	10.99	57.12	230.24
Unlevered Free Cash Flow, 5 Yr. CAGR %	69.93	-1.25	-0.19	26.56	55.86
Dividend Per Share, 5 Yr. CAGR %	3.37	-	-	-	-